CheckMate 067: Combined nivolumab and ipilimumab or monotherapy in untreated melanoma | Dr Paolo Ascierto at Annual Meeting 2015 - 101271

Spotlight
Video

CheckMate 067: Combined nivolumab and ipilimumab or monotherapy in untreated melanoma | Dr Paolo Ascierto at Annual Meeting 2015

EMJ has 458 videos Subscribe Here

Loading........
Description: At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Paolo A. Ascierto, MD, of Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy, discusses CheckMate 067, a randomised, double-blind, phase 3 trial of nivolumab monotherapy or nivolumab combined with ipilimumab versus ipilimumab monotherapy in patients with previously untreated unresectable or metastatic melanoma.
Shared By : EMJ
Posted on : 09/04/15
Added : 3 years ago